EPANOVA: payments to doctors
Payments that named EPANOVA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $255K
- Providers
- 112
- Transactions
- 271
- Average per transaction
- $941
The per-transaction average — $941 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 112 providers the average total is $2,276, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $237,817 | 93.3% |
| Acerta Pharma LLC | $13,375 | 5.2% |
| Astrazeneca UK Limited | $3,758 | 1.5% |